-
Sutra Medical to Present First-in-Human Case of the Sutra Hemi-Valve at TCT 2025
Lake Forest, CA – September 19 2025 – Sutra Medical Inc. is proud to announce that Dr. Sanjeevan Pasupati will present the First-in-Human (FIH) case of the Sutra Hemi-Valve at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) 2025 Conference. The case will be featured in: ✨ Innovation Session 17: New Generation Transcatheter Mitral Technologies: Case-in-a-Box Demonstrations
-
Sutra Medical Achieves World’s First Successful First-in-Human Implantation of Sutra Hemi-valve in New Zealand
Lake Forest, CA – August 31, 2025 – Sutra Medical, Inc. today announced the world’s first successful first-in-human (FIH) implantation of its Sutra Hemi-valve Transcatheter Mitral Valve Repair System at Waikato Hospital in New Zealand. The procedure was performed on an 83-year-old high-risk patient with severe (4+) functional mitral regurgitation (MR) and posterior leaflet tethering,
-
FIH Approval
Sutra Medical is delighted to announce that it has received approval to conduct First-in-Human (FIH) studies in Uzbekistan, New Zealand, and the Republic of Georgia.
-
Dr. Wei Sun as the CEO of Sutra Medical
Approved by the Board of Directors, Dr. Wei Sun is appointed as the CEO of Sutra Medical Inc. Dr. Sun has 20+ years of experience in the study of heart valve biomechanics. He has published over 100 journal papers and given over 200 presentations in conferences, workshops, and seminars. He is internationally recognized as a
